Infinity Pharmaceuticals Financial Indicators Patterns

INFI -- USA Stock  

USD 2.31  0.09  3.75%

We strongly advise you to harness analysis of Infinity Pharmaceuticals fundamentals to see if markets are presently mispricing the organization. We found thirty-four available reported financial drivers for Infinity Pharmaceuticals which can be compared to its competitors. To make sure the equity is not overpriced, please check out all Infinity Pharmaceuticals fundamentals including its Shares Owned by Institutions, Net Income, Earnings Per Share, as well as the relationship between Price to Sales and Current Ratio . Please also validate Infinity Pharmaceuticals Price to Earning to confirm the company can sustain itself down the road.Use Infinity Pharmaceuticals to protect against small markets fluctuations. The stock experiences unexpected downward movement. The market is reacting to new fundamentals. Check odds of Infinity Pharmaceuticals to be traded at $2.22 in 30 days

Enterprise Value

Infinity Pharmaceuticals Company Summary

Infinity Pharmaceuticals competes with China Cord, NantKwest, DelMar Pharmaceuticals, Denali Therapeutics, and Dova Pharmaceuticals. Infinity Pharmaceuticals, Inc., a biopharmaceutical company, develops medicines for people with cancer in the United States. Infinity Pharmaceuticals, Inc. is headquartered in Cambridge, Massachusetts. Infinity Pharmaceuticals operates under Biotechnology classification in USA and traded on BATS Exchange. It employs 22 people.

Infinity Pharmaceuticals Number of Shares Shorted vs Price to Book

Infinity Pharmaceuticals is rated below average in number of shares shorted category among related companies. It is rated below average in price to book category among related companies . The ratio of Number of Shares Shorted to Price to Book for Infinity Pharmaceuticals is about  382,143 

Infinity Pharmaceuticals Systematic Risk

The output start index for this execution was twelve with a total number of output elements of five. The Beta measures systematic risk based on how returns on Infinity Pharmaceuticals correlated with the market. If Beta is less than 0 Infinity Pharmaceuticals generally moves in the opposite direction as compared to the market. If Infinity Pharmaceuticals Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Infinity Pharmaceuticals is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Infinity Pharmaceuticals is generally in the same direction as the market. If Beta > 1 Infinity Pharmaceuticals moves generally in the same direction as, but more than the movement of the benchmark. View also all equity analysis or get more info about beta statistic functions indicator.

Distress Rating

Infinity Pharmaceuticals Financial Distress Probability

62% 
Chance of Financial Distress
Infinity Pharmaceuticals has more than 62 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info

Compare Infinity Pharmaceuticals

Compare Infinity Pharmaceuticals To Peers

Infinity Pharmaceuticals Opportunity Range

September 22, 2018 Opportunity Range

Please also check Risk vs Return Analysis. Please also try Price Ceiling Movement module to calculate and plot price ceiling movement for different equity instruments.
Search macroaxis.com